In their January 2022 EMM Editor’s Choice article, Waters et al. propose that the genotoxicity of molnupiravir (MOV), an antiviral with emergency use authorization for COVID-19 treatment, should be further investigated using human-centric methods before final FDA approval.
In their November 2021 EMM Editor’s Choice article, Mittelstaedt et al. demonstrate a tissue-specific, life-stage effect in EMS-induced genotoxicity between gpt-delta mice treated as adults and neonates.
The June 2021 EMM Editor's Choice article is “Implications of an epidemiological study showing an association between in utero NDMA exposure and childhood cancer” by Bevin Engelward.
In their August 2021 EMM Editor’s Choice article, Wang et al. demonstrate lead exposure in occupationally-exposed humans is associated with genotoxicity, and epigenetic mechanisms play a role in the lead-mediated genotoxicity.
In their April 2021 EMM Editor’s Choice article, Ursini et al. describe a method, the buccal micronucleus cytome (BMCyt) assay, for assessing the cyto–genotoxic risk of TiO2 occupational exposure.
